The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs. The company expects to employ 420 ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

A new biotechnology plant is set to boost North Carolina's economy by more than $3 billion. Medical manufacturing company ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

Roche’s Herceptin and Perjeta duo is already part of a well-established standard of care in early-stage HER2-positive breast ...